P-glycoproteins more efficient at limiting than inducing efflux of colchicine and vinblastine in HL-60 cells

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 712-718

  Declèves, Xavier ^a   Chappey, Olivier ^a,b   Boval, Bernadette ^b   Niel, Elisabeth ^a   Scherrmann, Jean Michel ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Colchicine; Flow cytometry; P glycoprotein; Verapamil; Vinblastine

Indexed keywords

COLCHICINE; GLYCOPROTEIN P; VERAPAMIL; VINBLASTINE; ANTIARRHYTHMIC AGENT; ANTIGOUT AGENT; ANTINEOPLASTIC AGENT;

ARTICLE; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KINETICS; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-ARRHYTHMIA AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; COLCHICINE; GOUT SUPPRESSANTS; HL-60 CELLS; HUMANS; P-GLYCOPROTEIN; VERAPAMIL; VINBLASTINE;

EID: 0032060788     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011914902121     Document Type: Article

References (26)

1. M. Bar-Eli, M. Ehrenfeld, M. Levy, R. Gallily, and M. Eliakim. Leukocytes chemotaxis in recurrent polyserotisis (familial mediterranean fever). Am. J. Med. Sci. 281:5-8 (1981).
2. O. Chappey, E. Niel, J. L. Wautier, P. Pham Hung, M. Dervichian, D. Cattan, and J. M. Scherrmann. Colchicine disposition in human leucocytes after single and multiple oral administration. Clin. Pharmacol. Ther. 54:360-367, (1993).
3. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62:385-427, (1993).
4. A. Schinkel, C. Mol, E. Wagenaar, L. van Deemter, J. Smit, and P. Borst. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer 31A: 1295-1298 (1995).
5. K. V. Speeg, A. L. Maldonado, J. Liaci, and D. Muirhead. Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. J. Pharmacol. Exp. Ther. 261:50-55 (1992).
6. K. V. Speeg, A. L. Maldonado, J. Liaci, and D. Muirhead. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology 15:899-903 (1992).
7. W. Klimecki, B. Futscher, T. Grogan, and W. Dalton. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458 (1994).
8. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Research 41:1967-1972 (1981).
9. K. Jönsson, N. Dahlberg, U. Tidefelt, C. Paul, and G. Andersson. Characterization of an anthracycline resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression. Biochem. Pharmacol. 49:755-762 (1995).
10. O. Chappey, E. Niel, M. Debray, J. L. Wautier, and J. M. Scherrmann. Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments. J. Pharmacol. Exp. Ther. 274:1072-1076 (1995).
11. G. Su, M. Davey, R. Davey, and A. Kidman. Development of extended multidrug resistance in HL-60 promyelocytic leukemia cells. Br. J. Haematology 88:566-574 (1994).
12. O. Lowry, N. Rosebrough, A. Farr, and R. Randall. Protein mesurement with Folin phenol reagent. J. Biol. Chem. 193:265-273 (1951).
13. M. Cornwell, M. Gottesman, and I. Pastan. Increased vinblastine binding to membrane vesicles from multidrug resistant K. B.cells. J. Biol. Chem. 261:7921-7928 (1986).
14. A. Safa, N. Mehta, and M. Agresti. Photoaffinity labelling of P-Glycoprotein in multidrug resistant cells with photoactive analogs of Colchicine. Biochem. Biophys. Res. Commun. 162:1402-1408 (1989).
15. A. Reichel, Z. Reeve-Chen, D. Begley, and J. Abbott. A method to assess functional activity of P-glycoprotein in vitro based on the energy requirements of the transporter. In P. O. Couraud and D. Scherman (eds.), Biology and Physiology of the blood-brain-barrier: Transports, cellular interactions and brain pathologies, Plenum Press, New York, 1997, pp. 183-187.
16. N. Greig, T. Soncrant, H. Shetty, S. Momma, Q. Smith, and S. Rapoport. Brain uptakes and anti-cancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother. Pharmacol. 26:263-268 (1990).
17. A. Safa. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. 85:7187-7191 (1988).
18. D. Ferry, M. Russell, and M. Cullen. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site. Biochem. Biophys. Res. Commun. 188:440-445 (1992).
19. V. Vollrath, A. Wielandt, C. Acuna, I. Duarte, L. Andrade, and J. Chianale. Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver. J. Hepatalogy 21:754-763 (1994).
20. D. Panda, J. Daijo, M. Jordan, and L. Wilson. Kinetic stabilization of microtubule dynamics at steady state in vitro by substoichiometric concentrations of tubulin-colchicine complex. Biochemistry 34:9921-9929 (1995).
21. J. Diaz and J. Andreu. Kinetics of dissociation of the tubulin-colchicine complex. J. Biol. Chem. 266:2890-2896 (1991).
22. L. Wilson and M. Jordan. Pharmacological probes of microtubule function. In J. S. Hyams and C. W. Lloyd (eds.), Microtubules 13, Wiley-liss, New York, 1994, pp. 59-83.
23. A. Molinari, M. Cianfriglia, S. Meschini, A. Calcabrini, and G. Arancia. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer 59:789-795 (1994).
24. N. Baldini, K. Scotlandi, M. Serra, T. Shikita, N. Zini, A. Ognibene, S. Santi, R. Ferracini, and N. Maraldi. Nuclear immunolocalization of P-glycoprotein in multidrug resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur. J. Cell. Biol. 68:226-239 (1995).
25. M. Dordal, M. Jackson-Stone, A. Ho, J. Winter, and A. Atkinson Jr. Decreased intracellular compartmentalization of doxorubucin in cell lines expressing P-glycoprotein. J. Pharmacol. Exp. Ther. 271:1286-1290 (1994).
26. U. Consoli, W. Priebe, Y. H. Ling, R. Mahadevia, M. Griffin, S. Zhao, R. Perez-Soler, and M. Andreef. The novel anthracycline annamycin is not affected by P-glycoprotein-relatedmultidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Blood 88:633-644 (1996).